MICHAEL HOVEY

MASON, OH

General Payments — all program years on this page

$212.65

  • Category: General Payments
  • Program years: PY2022
  • Record count: 20
  • As of (CMS publication): 2026-01-23

Latest program year (PY2022): $212.65 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2022) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $212.6520

By paying entity

Latest program year (PY2022) · sorted by reported total.

Paying entityAmountRecords
ACADIA Pharmaceuticals Inc $212.6520

By program year

Program yearAmountRecords
2022 $212.6520

Records — PY2022 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
952409689 ACADIA Pharmaceuticals Inc $2.54 01/27/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409691 ACADIA Pharmaceuticals Inc $3.50 01/27/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409693 ACADIA Pharmaceuticals Inc $5.25 01/28/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409695 ACADIA Pharmaceuticals Inc $2.24 02/02/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409697 ACADIA Pharmaceuticals Inc $5.25 02/02/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409699 ACADIA Pharmaceuticals Inc $3.80 02/24/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409701 ACADIA Pharmaceuticals Inc $1.35 02/24/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409703 ACADIA Pharmaceuticals Inc $4.30 02/24/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409705 ACADIA Pharmaceuticals Inc $3.94 03/03/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409707 ACADIA Pharmaceuticals Inc $4.36 03/03/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409709 ACADIA Pharmaceuticals Inc $5.00 04/07/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409711 ACADIA Pharmaceuticals Inc $2.04 04/07/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409713 ACADIA Pharmaceuticals Inc $5.38 06/06/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409715 ACADIA Pharmaceuticals Inc $5.25 07/26/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409717 ACADIA Pharmaceuticals Inc $3.50 08/09/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409719 ACADIA Pharmaceuticals Inc $8.36 08/09/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409721 ACADIA Pharmaceuticals Inc $8.96 08/12/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409723 ACADIA Pharmaceuticals Inc $5.63 08/12/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409725 ACADIA Pharmaceuticals Inc $7.00 08/25/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
952409727 ACADIA Pharmaceuticals Inc $125.00 10/21/2022 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.